In addition, METTL3, METTL14, and ALKBH5 have been reported in studies of promoting and inhibiting breast cancer, suggesting that they may play both oncogenic and anti-oncogenic roles in breast cancer (Gong et al., 2020[63]; Li et al., 2024[138]; Xu et al., 2023[308]; Wang et al., 2024[247]; Sun et al., 2020[224]; Woodcock et al., 2024[288]; Liu et al., 2022[149]). This evidence concerns the gene METTL14 and breast carcinoma.